GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Apollo Hospitals Enterprise Ltd (NSE:APOLLOHOSP) » Definitions » ROE %

Apollo Hospitals Enterprise (NSE:APOLLOHOSP) ROE % : 15.08% (As of Dec. 2023)


View and export this data going back to 1996. Start your Free Trial

What is Apollo Hospitals Enterprise ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Apollo Hospitals Enterprise's annualized net income for the quarter that ended in Dec. 2023 was ₹9,812 Mil. Apollo Hospitals Enterprise's average Total Stockholders Equity over the quarter that ended in Dec. 2023 was ₹65,086 Mil. Therefore, Apollo Hospitals Enterprise's annualized ROE % for the quarter that ended in Dec. 2023 was 15.08%.

The historical rank and industry rank for Apollo Hospitals Enterprise's ROE % or its related term are showing as below:

NSE:APOLLOHOSP' s ROE % Range Over the Past 10 Years
Min: 3.58   Med: 8.87   Max: 20.65
Current: 12.66

During the past 13 years, Apollo Hospitals Enterprise's highest ROE % was 20.65%. The lowest was 3.58%. And the median was 8.87%.

NSE:APOLLOHOSP's ROE % is ranked better than
73.61% of 610 companies
in the Healthcare Providers & Services industry
Industry Median: 4.115 vs NSE:APOLLOHOSP: 12.66

Apollo Hospitals Enterprise ROE % Historical Data

The historical data trend for Apollo Hospitals Enterprise's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apollo Hospitals Enterprise ROE % Chart

Apollo Hospitals Enterprise Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.17 13.64 3.79 20.65 13.86

Apollo Hospitals Enterprise Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.25 9.33 10.75 14.31 15.08

Competitive Comparison of Apollo Hospitals Enterprise's ROE %

For the Medical Care Facilities subindustry, Apollo Hospitals Enterprise's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Apollo Hospitals Enterprise's ROE % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Apollo Hospitals Enterprise's ROE % distribution charts can be found below:

* The bar in red indicates where Apollo Hospitals Enterprise's ROE % falls into.



Apollo Hospitals Enterprise ROE % Calculation

Apollo Hospitals Enterprise's annualized ROE % for the fiscal year that ended in Mar. 2023 is calculated as

ROE %=Net Income (A: Mar. 2023 )/( (Total Stockholders Equity (A: Mar. 2022 )+Total Stockholders Equity (A: Mar. 2023 ))/ count )
=8191/( (56233+61974)/ 2 )
=8191/59103.5
=13.86 %

Apollo Hospitals Enterprise's annualized ROE % for the quarter that ended in Dec. 2023 is calculated as

ROE %=Net Income (Q: Dec. 2023 )/( (Total Stockholders Equity (Q: Sep. 2023 )+Total Stockholders Equity (Q: Dec. 2023 ))/ count )
=9812/( (65086+0)/ 1 )
=9812/65086
=15.08 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2023) net income data. ROE % is displayed in the 30-year financial page.


Apollo Hospitals Enterprise  (NSE:APOLLOHOSP) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=9812/65086
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(9812 / 194024)*(194024 / 155609)*(155609 / 65086)
=Net Margin %*Asset Turnover*Equity Multiplier
=5.06 %*1.2469*2.3908
=ROA %*Equity Multiplier
=6.31 %*2.3908
=15.08 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=9812/65086
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (9812 / 14532) * (14532 / 17868) * (17868 / 194024) * (194024 / 155609) * (155609 / 65086)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.6752 * 0.8133 * 9.21 % * 1.2469 * 2.3908
=15.08 %

Note: The net income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Apollo Hospitals Enterprise ROE % Related Terms

Thank you for viewing the detailed overview of Apollo Hospitals Enterprise's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Apollo Hospitals Enterprise (NSE:APOLLOHOSP) Business Description

Traded in Other Exchanges
Address
No. 8-17 Shafee Mohammed Road, Sunny Side Building, East Block, 3rd Floor, Chennai, TN, IND, 600 006
Apollo Hospitals Enterprise Ltd operates a network of private hospitals in India through primary, secondary, and tertiary care facilities. The firm's tertiary care hospitals provide complex care in a variety of specialties that include cardiology, oncology, neuroscience, orthopedics, radiology, and gastroenterology. Apollo Hospitals also operates primary care and diagnostics clinics as well as telemedicine units and offers consulting, health insurance, education and training, and research services. The firm receives the most proportion of revenue from its core healthcare business. The firm's standalone pharmacy segment contributes the second largest proportion of revenue.

Apollo Hospitals Enterprise (NSE:APOLLOHOSP) Headlines

No Headlines